Orencia (Abatacept)

Abatacept, the active ingredient in Orencia, is an immunomodulator presented as an injection for intravenous use. It treats rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis in adult and pediatric patients. GNH USA supplies Orencia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Orencia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Orencia is a biologic disease‑modifying antirheumatic drug that targets immune‑driven joint disease.

- Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Juvenile idiopathic arthritis: improves joint function and decreases disease activity. - Psoriatic arthritis: alleviates skin and joint symptoms and limits progression.

Adverse reactions to abatacept may vary in frequency and severity.

Common Side Effects: - Upper respiratory tract infection - Headache - Nausea - Hypertension - Infusion‑related reactions

Serious or Rare Side Effects: - Severe infections (e.g., tuberculosis) - Malignancies - Autoimmune disorders - Progressive multifocal leukoencephalopathy (PML) - Anaphylaxis

When using Orencia, clinicians should consider several safety measures.

- Infection risk: assess for active infections before starting therapy. - Vaccination: avoid live vaccines during treatment. - Monitoring: conduct regular laboratory tests to track blood counts and liver function. - Pregnancy: use only if the potential benefit justifies the potential risk. - Breastfeeding: weigh benefits against possible drug exposure to the infant. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Abatacept may interact with other medications, requiring careful management.

Major Interactions (Avoid): - Live vaccines: may cause severe infection. - Strong immunosuppressants: increase risk of serious infections.

Moderate Interactions (Monitor Closely): - Antiviral agents: may alter immune response. - Corticines [sic] ** - Medications  ​  ​  ****  ****  ****  ****  ****  ****  ****  ****  ****  ****  ****  ****  **** **** **** **** **** **** **** **** **** **** **** **** **** **** **** **** -  ****   ****